Results 201 to 210 of about 82,791 (297)

Ruxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals: A randomized trial

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In adults with moderate AD post‐TCS and ‐TCI, who may otherwise be eligible for systemic therapy, 1.5% ruxolitinib cream improved clinical signs and symptoms in the TRuE‐AD4 study. Abstract Background In patients with moderate atopic dermatitis (AD), topical corticosteroids (TCS) and topical calcineurin inhibitors (TCI) often do not sufficiently ...
José Manuel Carrascosa   +14 more
wiley   +1 more source

calcineurin

open access: yesJournal of JCS Cardiologists, 2001
openaire   +2 more sources

Management of chronic urticaria: Current status and future prospect

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Chronic urticaria is driven by mast cell activation through autoimmune, inflammatory, and neuroimmune pathways. A structured approach combining diagnosis, patient‐reported outcomes, stepwise therapy, treatment optimization, monitoring and emerging targeted agents may improve disease control and enable more personalized management.
Andaç Salman   +15 more
wiley   +1 more source

Male genital lichen sclerosus

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Male genital lichen sclerosus is driven by chronic, occluded exposure of susceptible genital epithelium to urine, rather than infection or autoimmunity. This review synthesizes clinical, anatomical and molecular evidence showing how microincontinence and occlusion initiate inflammation, fibrosis and carcinogenesis, and explains the curative effect of ...
Georgios Kravvas   +3 more
wiley   +1 more source

Treatment strategies for interstitial granulomatous dermatitis: Systematic review and expert opinion

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Systematic review of 108 studies with a total of 182 patients with interstitial granulomatous dermatitis (IGD). IGD was frequently associated with systemic conditions or drug exposure. Management includes careful medication review and prompt withdrawal of potential triggers. Corticosteroids (systemic and topical) were commonly effective, while biologic
Francesco Bellinato   +4 more
wiley   +1 more source

Early systemic intervention for vitiligo: A prospective bicentric interventional study

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Patients with non‐segmental vitiligo were enrolled into three groups according to the duration and activity of their disease. All subjects received NB‐UVB phototherapy and an oral mini‐pulse of systemic corticosteroids twice weekly for 6 months. Early systemic treatment allows better repigmentation, including in difficult‐to‐treat areas.
Clemence Bertold   +8 more
wiley   +1 more source

Planning Intermittent CalciNeurin Inhibitor Controls-The piCNIc Retrospective Cohort Study. [PDF]

open access: yesClin Transplant
Bellissimo V   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy